Jack Nielsen
CIK 1602402 · last filed 2024-05-31
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$96.26M
Companies
7
Total Filings
52
Lifetime Open-Market Net
-$80.18M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| HRMY | Director | 2,571,024 | $35.80 | $92.04M | -$95.31M | 29 | 2024-05-31 |
| ALGS | Director | — | $4.69 | — | $0 | 4 | 2024-02-28 |
| TIL | Director | 585,485 | $7.20 | $4.22M | $6.00M | 4 | 2024-01-10 |
| ALXO | Director | — | $2.02 | — | $0 | 4 | 2023-06-22 |
| IO Biotech, Inc. (IOBT) Delisted | Director | 2,365,545 | $0.05 | $113.5K | $9.10M | 3 | 2023-06-13 |
| REATA PHARMACEUTICALS INC (RETA) Delisted | Director | 1,780 | $172.36 | $306.8K | $30.3K | 7 | 2021-06-14 |
| CRNX | Director | — | $83.65 | — | $0 | 1 | 2019-06-25 |
Recent Filings · Page 5 of 6
52 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-03-22 | TIL | Grant (A) | — | $0 | EDGAR |
| 2020-08-27 | HRMY | Buy (P) | +4,745 | $162.7K | EDGAR |
| 2020-08-24 | HRMY | Buy (P) | +37,957 | $1.05M | EDGAR |
| 2020-08-20 | HRMY | Grant (A) | — | $0 | EDGAR |
| 2020-07-17 | ALXO | Grant (A) | — | $0 | EDGAR |
| 2020-06-22 | REATA PHARMACEUTICALS INC (RETA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-06-25 | CRNX | Grant (A) | — | $0 | EDGAR |
| 2019-06-13 | REATA PHARMACEUTICALS INC (RETA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-06-14 | REATA PHARMACEUTICALS INC (RETA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-06-15 | REATA PHARMACEUTICALS INC (RETA) Delisted | Grant (A) | — | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.